Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Ambir Technology, Inc. Introduces Fax Capabilities to Scanners


Ambir Technology, the global leader in sheet-fed and ADF scanner products, has announced their partnership with etherFAX and the introduction of fax capabilities for Ambir scanners. This partnership will bring increased productivity, security and value to Ambir and etherFAX customers.

EtherFAX compatibility ensures secure, HIPAA compliant, data transfer that eliminates the need for a separate fax machine. With the addition of fax capabilities to the AmbirScan software, your scanner can quickly and easily scan information before faxing it to your desired source. Securely transfer data and manage critical fax communication for your business quickly and easily with this new capability.

Ambir’s AmbirScan software helps you work faster with automatic card orientation detection and quick scan features. It makes scanning and faxing fast, easy and accurate, optimizing your productivity and saving your time. And by faxing through the etherFAX’s SENx Secure Exchange Network with ECIES encryption, faxed information is encrypted to ensure maximum security during transfer.

Fax capabilities are available in AmbirScan for a wide variety of Ambir sheetfed and card scanners. The nScan DS690gt, ImageScan Pro DS687, ImageScan Pro PS667, ImageScan Pro 490i and the TravelScan Pro 600 will also be compatible for fax functionality. These scanners have small footprints and utilize USB power to ensure you can securely scan and transfer information in a variety of locations. Scan and fax with ease from your home office, on the road, or anywhere else you need.

About Ambir Technology

Ambir Technology, Inc. is an industry leader in digital capture and document management solutions. Combining professional-grade ID card and document scanners, unique digital imaging software and expert-level customer service, Ambir provides their customers with comprehensive, enterprise-level document capture and form solutions. Specializing in the healthcare, legal and financial sectors, Ambir helps organizations reduce costs, increase productivity and strengthen data security. For more information, visit http://www.ambir.com

About etherFAX

Founded in 2009, etherFAX® offers a unique solution that extends existing fax server solutions to the cloud. By eliminating the need for costly network fax systems, such as fax boards and recurring telephony fees, etherFAX’s patented technology leverages the Internet to manage all business-critical fax communications.

Share article on social media or email:

Biomeme SARS-CoV-2 Test Approved by FDA Under Emergency Use Authorization


Biomeme's End-to-End SARS-CoV-2 Real-Time RT-PCR Test

Biomeme’s End-to-End SARS-CoV-2 Real-Time RT-PCR Test

Biomeme, Inc. announced today that the U.S. Food and Drug Administration (FDA) gave Biomeme’s SARS-CoV-2 Real-Time RT-PCR Test Emergency Use Authorization (EUA) for use in any lab CLIA-certified to perform high complexity testing. It is intended for use by qualified and trained clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures.

About Biomeme’s SARS-CoV-2 Test

The Biomeme SARS-CoV-2 Real-Time RT-PCR Test is designed to detect the virus’ Orf1ab and S genes in nasopharyngeal, nasal, and oropharyngeal swab specimens, as well as nasopharyngeal wash/aspirate or nasal aspirate specimens. Unlike wet assays, which must be stored frozen and require pipetting of multiple reagents by an experienced biologist, Biomeme’s SARS-CoV-2 test is lyophilized (freeze-dried) to not only maximize shelf-life but to also enable easier transportation and storage without a cold chain.

Each test is a ready-to-use formulation that largely simplifies assay setup because each reaction well already contains the necessary master mix, enzymes, and multiplexed primers and probes. The test also includes Biomeme’s RNA Process Control (RPC) for RNA extraction and RT-PCR to identify potential inhibition in RNA samples, differences in sample handling, or an issue with the reagents.

The test utilizes Biomeme’s DNA/RNA Preservation Buffer for sample collection, M1 Sample Prep Cartridge for RNA extraction, and Biomeme’s portable Franklin™ Real-Time qPCR Thermocycler using it’s 3-well Go-Strips. Franklin’s companion mobile app, Biomeme Go, is used to run the tests and display test results in real-time for fast, simple interpretation. The test can also be used with the BD swab collection kit with VTM and can be run using Biomeme’s 96-well Go-Plates on lab-bound PCR systems such as Bio-Rad’s CFX96 or Applied Biosystems Quant Studio 5. Whether using Biomeme’s portable thermocycler to run up to 9 samples simultaneously or a lab thermocycler like the CFX96 or ABI QS5 to run up to 96 reactions, you can expect test results in as little as 1 hour.

Biomeme’s test was approved for emergency use by Health Canada in June and is currently in a number of satellite labs and low-resource settings, including an Ontario mining company, New Gold Inc. New Gold CEO Renaud Adams has been dedicated to establishing a COVID-free workplace and quickly adopted Biomeme’s test. “It’s a new technology,” Adam’s said to CBC News. “We’re prepared, you know, to have a period of adjustment if need be. But at the end of the day, it could only be positive.”

Key Differences Between Biomeme’s Test Kits and Others

There are considerable advantages to using Biomeme’s SARS-CoV-2 test in comparison to others:

Efficient – A multiplexed reaction means that all targets are in a single reaction. So, a single reaction equates to a single sample.

RNA Process Control (RPC) – As mentioned earlier, Biomeme’s test kits include a quantified exogenous positive control. It is a shelf-stable, lyophilized pellet of MS2 bacteriophage that you can expect to be detected around the same Cq every time.

Concentrated – Because the Biomeme test is lyophilized, you are able to add more sample (“template”) to the test (20 µL), which will directly increase sensitivity without throwing off your reagent concentrations.

Shelf-Stable – Most assays require shipment on dry ice and storage in a -80°C freezer, increasing the risk of components going bad due to freeze and thaw cycles. With Biomeme’s test assay, there is no need for refrigeration, lab equipment, or mixing of wet reagents. Just add your purified RNA and get testing.

Pre-Mixed & Pre-Aliquoted – Most assays come as multiple, separate components in bulk and need to be mixed and aliquoted by an experienced molecular biologist, further increasing the risk of contamination. There is no mixing or aliquoting of components required with Biomeme’s test. It’s already taken care of.

Biomeme co-founder and Biology Lead, Jesse vanWestrienen, took the lead on developing Biomeme’s test in February when SARS-CoV-2 was still primarily contained in Asia and eastern Europe. Jesse saw that the virus had the potential to affect the United States and quickly got to work developing a solution using Biomeme’s field-ready products and his years of expertise. Jesse says, “one of the main reasons my co-founders and I founded Biomeme was that we wanted real-time PCR to be very accessible.” Biomeme’s technology applied to SARS-CoV-2 gives healthcare providers the ability to rapidly detect the virus so that infected patients can be quarantined and treated to slow down the spread of COVID-19 no matter how remote the test site may be.

EUA Approved COVID-19 Test Form Factors by Use Case

Biomeme Go-Strips™ are pre-cut and pre-aliquoted trays of (32) 3-well Go-Strips. Each well contains a 20 µL lyophilized triplex reaction. This form factor is ideal for CLIA high complexity laboratories requiring overflow testing, as well as operating lower throughput testing in remote locations and temporary test sites. When used with the internally battery-powered Biomeme Franklin™ Real-Time qPCR Thermocycler, you can test up to 9 samples using three Biomeme Go-Strips™ within 60 minutes.

Biomeme Go-Plates™ are 96-well plates that contain a 20 µL lyophilized triplex reaction in each well. Go-Plates™ can be used on the Bio-Rad CFX96, the Applied Biosystems QuantStudio 5 thermocycler, or even cut into 3-well, 6-well, or 9-well strips for use in the Biomeme™ Franklin Real-Time PCR Thermocycler. Go-Plates™ are ideal for central labs and other test sites that require higher throughput testing.

Biomeme is currently working with CLIA high complexity labs that are in need of a medium-throughput alternative for overflow testing in their high-throughput labs or adding mobile testing capabilities to their satellite labs. For organizations without their own CLIA high complexity labs but that still want to offer testing, Biomeme asks that you contact their subsidiary CLIA high complexity lab, One Health Labs, to get started.

About Biomeme

Biomeme entered into molecular detection in 2012 when it created the first smartphone add-on capable of performing real-time PCR. Since its inception, Biomeme has used advanced biology and chemistry, world-class hardware and software engineering, to create elegant solutions to complex problems. Headquartered in Philadelphia, USA, Biomeme offers a full suite of end-to-end mobile molecular solutions that perform to the gold standard used by the world’s most advanced central labs yet require no lab equipment or specialized experience to use. To find out more about Biomeme, visit biomeme.com.

Share article on social media or email:

We Made The List! 2020 Inc. 5000


News Image

Inc. Magazine Unveils Its Annual List of America’s Fastest-Growing Private Companies—the Inc. 5000

TheraEx Rehab Services, Inc. Ranks No. 1178 on the 2020 Inc. 5000 With Three-Year Revenue Growth of 384% Percent

Inc. magazine today revealed that TheraEx Rehab Services, Inc. is No. 1178 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

“PEOPLE OVER PROFITS.”

Not only have the companies on the 2020 Inc. 5000 been very competitive within their markets, but the list as a whole shows staggering growth compared with prior lists as well. The 2020 Inc. 5000 achieved an incredible three-year average growth of over 500 percent, and a median rate of 165 percent. The Inc. 5000’s aggregate revenue was $209 billion in 2019, accounting for over 1 million jobs over the past three years.

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at http://www.inc.com/inc5000. The top 500 companies are also being featured in the September issue of Inc., available on newsstands August 18.

“The companies on this year’s Inc. 5000 come from nearly every realm of business,” says Inc. editor-in-chief Scott Omelianuk. “From health and software to media and hospitality, the 2020 list proves that no matter the sector, incredible growth is based on the foundations of tenacity and opportunism.”

The annual Inc. 5000 event honoring the companies on the list will be held virtually from October 23 to 27, 2020. As always, speakers will include some of the greatest innovators and business leaders of our generation.

WE PROVIDE NURSING AND ALLIED STAFFING TO HOSPITALS

CONTACT: REY DAVID RIVERA, (510)239-9614, REY@THERAEXSTAFFING.COM

More about Inc. and the Inc. 5000

Methodology

The 2020 Inc. 5000 is ranked according to percentage revenue growth when comparing 2016 and 2019. To qualify, companies must have been founded and generating revenue by March 31, 2016. They had to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2019. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2016 is $100,000; the minimum for 2019 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Companies on the Inc. 500 are featured in Inc.’s September issue. They represent the top tier of the Inc. 5000, which can be found at http://www.inc.com/inc5000.

About Inc. Media

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit http://www.inc.com.

For more information on the Inc. 5000 Conference, visit http://conference.inc.com/.

Share article on social media or email:

First-Ever Consumer DNA Test to Unlock the Connection Between Genetics and Mental Wellness-Related Behavioral Tendencies


Living with a mental health challenges can be stressful even during the best of times. Then COVID-19 came along. Quarantine, distancing, not seeing family and loved ones, and economic worries have all added to the struggles of people dealing with mental wellness. On top of that, back-to-school stress is compounding the mental stressors we’re all dealing with right now. Recently, Amy Edgar, Founder of Children’s Integrated Center for Success and expert in pediatric mental health, teamed with YourUpdateTV to discuss steps we can take to take control of our mental wellness during this uncertain time.

A video accompanying this announcement is available at: https://youtu.be/0WpBE2FWYC0

Parents, many of whom may be dealing with their own mental and emotional struggles, have taken on the burden of worrying about their child’s mental health as well. With the back to school season in full swing, stress and anxiety are at an all-time high as families grapple with the reality of additional distance learning, or the potential dangers of returning to the classroom. It’s natural for parents to wonder whether the last five months – and whatever lies ahead – will have a lasting effect on kids’ mental well-being.

So how can parents take back control of mental wellness in the age of COVID-19?

A first-ever consumer DNA test is helping unlock the connection between genetics and mental wellness. One cheek swab will produce results that will help people better understand how genes affect one’s predisposition for stress, focus, substance abuse, sleep, and more.

Organized around Genomind’s proprietary ‘7 Core Genetic Mental Health Capabilities™’, the test analyzes 38 genetic variants and their influence on 29 mental health traits. The result is an interactive report that details 59 possible behavioral predispositions specific to each user’s genetic profile, along with resources and actionable recommendations shown to improve wellness and quality of life. Genomind Mental Health Map is the only DNA test in the consumer market with a specific focus on mental health and wellness, and is available without prescription. The test should not be used as a diagnostic or risk assessment for mental health diseases and disorders.

For more information, visit MentalHealthMap.com and use discount code “MHMFALL5.”

About Amy Edgar, APRN, CRNP, FNP-C:

Amy Edgar is transforming healthcare and embracing our next generation of humans. Ignited by the experience of raising her now 19-year old daughter, Amy founded the Children’s Integrated Center for Success in 2014. Weaving together the threads of mom, entrepreneur, teacher, nurse, primary care provider, and science geek, Amy utilizes systems thinking and integrated care delivery models to run her primary care center focused on children with behavioral health needs. From cutting edge genetics research to nutrition consults, speech and equine therapy, school advocates, and marriage counselors – CICS strives to reach every child, every time. In 2017, Amy led CICS in connecting career opportunities for children with autism looking for suitable work to capture their own piece of the American Dream, which was realized in the CICS Foundation. Amy continues to practice and provide patient care while championing CICS’s virtual healthcare expansion to reach families across and outside of Pennsylvania.

About Genomind:

Genomind is a leading mental health company singularly focused on filling the innovation gap in mental health care through novel, genetics-based tools that bring mental health into the era of personalized medicine. Its flagship product, Genomind Professional PGx, is a pharmacogenetic testing service that helps medical professionals guide patients’ mental health treatment. The Company recently launched Genomind Mental Health Map – a direct-to-consumer test that enables a better understanding of the biological basis of mental health, coupled with actionable guidance to help people improve health and wellness. Supported by a world-class genetics lab, a unique heritage of clinical mental health expertise, and a consultative approach, Genomind is advancing a new paradigm of precision medicine in mental health care. Learn more at http://www.genomind.com.

About YourUpdateTV:

YourUpdateTV is a social media video portal for organizations to share their content.

Share article on social media or email:

American Elite Molding Forms New Company to Begin U.S. Production of Filter Material for Personal Protective Equipment


No longer will China control the supply of this vitally important material. We will provide American-made filter material for medical grade masks and gowns.

American Elite Molding, America’s leading manufacturer of cable ties, proudly announces the start-up of a new company to address the dire need for U.S.-manufactured materials for the personal protective equipment market in the United States. The new company, American Elite Personal Protective Equipment (American Elite PPE), will begin production of melt blown polypropylene, the critical filter medium used in medical grade face masks and gowns, in early September 2020.

The COVID-19 pandemic has highlighted the fact that the supply of materials used to make personal protective equipment comes primarily from offshore manufacturers, and the risks of that have become apparent as widespread delays, shortages, and quality issues have occurred. The key to highly effective masks and gowns is the layer of melt blown polypropylene. This material filters very small particles and organisms efficiently while allowing enough porosity to breathe easily. American Elite PPE is gaining U.S. control of this crucial product by investing in its own manufacturing facility and establishing a U.S.-based supply chain.

American Elite PPE will manufacture melt blown filter material, the critical medium used in medical grade face masks and gowns, using polypropylene sourced from U.S. manufacturers. The filtering material will be made in the company’s Florida location by American workers, using equipment that has been designed, manufactured, and machined in the U.S. with advanced machining techniques used in domestic high tech industries.

American Elite PPE is currently taking orders for deliveries of the melt blown filter material, in bulk and custom cut rolls, beginning in September of this year. To order, call Ty Whitacre at 1-260-438-4491 or email Ty@aem-ties.com.

“No longer will China control the supply of this vitally important material,” said American Elite Molding Founder and CEO Robert Sires. “We are proud to be an American manufacturer that produces more than 1.5 billion cable ties in the United States utilizing American-made raw material and supplies. We have proven ourselves to be highly competitive with manufacturers in China and other offshore locations. Now, through our new company American Elite PPE, we will provide American-made products for the personal protective equipment that our front line healthcare providers, first responders, and citizens are so dependent upon. Our production lines are staffed by Americans who are committed to manufacturing the highest quality filter material. We manufacture to tight specifications so our customers can trust that they are getting the protection they need. We believe that during this crisis, it’s vital for the U.S. to secure a reliable, sustainable source of PPE material supply for critical healthcare needs, and for Americans to buy from U.S. businesses to support our economy and our workers. This new initiative delivers on both counts.”

American Elite PPE is America’s trusted manufacturing source for critical filter material, setting the standard for this vital material used in personal protective equipment. The company’s vision is to protect families, healthcare workers, first responders, and workers in industry with its American-made melt blown nonwoven polypropylene. American Elite PPE is proud to offer this critical filtering medium made from raw materials produced in the United States, processed on equipment built in the United States and operated by American workers. For more information, visit http://www.ae-ppe.com.

Celebrating its 22nd anniversary, American Elite Molding is the parent company of American Elite PPE and America’s leading manufacturer of nylon cable ties. Located in Crestview, Florida, its state-of-the-art ISO 9001-certified facility operates 24/7/365 and boasts the most advanced production processes in the U.S. AEM offers an extensive line of cable ties in a variety of lengths, tensile strengths, and colors, plus accessories such as mounting pads and cable clamps. American Elite Molding’s specialty products include EZ-Off™ ties, releasable ties, custom-printed ties, and HVAC duct straps. All cable ties use virgin nylon 6/6 to guarantee superior quality and are UL Listed and Mil-Spec approved, including UL 62275 Type 21S. Every cable tie and fastener AEM makes uses materials that are 100% made in America from start to finish. Vydyne® PA66 is entirely manufactured in America by Ascend Performance Materials and is designed to perform in the toughest environments. AEM maintains a full inventory of all cable ties for Just-in-Time delivery from regional stocking locations to its national distributor network. American Elite Molding is committed to continuous improvement in quality and service in all areas. The company focuses on customer success as well as satisfaction, and all American Elite Molding products are backed by a 100% satisfaction guarantee. For more information, call 1-888-463-3454, visit http://www.AmericanEliteMolding.com, or find AEM on Facebook.

Share article on social media or email:

UMD Spearheads the Development of a Novel Lyme Disease Vaccine, Leading a New $3.5 Million Grant


Borrelia burgdorferi, the pathogen causing Lyme disease, in a group of cells under a transmission electron microscope. Credit: Utpal Pal's lab

Borrelia burgdorferi, the pathogen causing Lyme disease, in a group of cells under a transmission electron microscope. Credit: Utpal Pal’s lab

“Borrelia infection is treatable with antibiotics, but you have a substantial fraction of patients that develop post-treatment Lyme Disease Syndrome. There is no cure for that, no drug, and no treatment. The only way to prevent this is to prevent Lyme, and a vaccine is a good answer,” says Pal.

In the heart of tick season and with COVID-19’s affinity for those who are immunocompromised, contracting Lyme disease is particularly concerning now and in the coming years. Addressing the need for an effective Lyme disease vaccine to prevent the upwards of 300,000 new cases in the U.S. alone each year and reduce the burden of chronic or post-treatment Lyme disease, the University of Maryland (UMD) is leading a new $3.5 million grant from the National Institutes of Health (NIH) to develop a novel “next-generation” Lyme disease vaccine. Collaborating with Thomas Jefferson University’s Jefferson Vaccine Center, Utpal Pal, professor in Veterinary Medicine at UMD, will use his expertise as a renowned tick immunobiologist to adapt the safe and effective rabies vaccination platform to produce antibodies that can provide protection against Borrelia burgdorferi, the bacteria responsible for Lyme disease, with the hope of applying this work to other tick-borne diseases in the future.

“Borrelia infection is treatable with antibiotics, but it is often misdiagnosed, and you have a substantial fraction of antibiotic-treated Lyme patients that develop a variety of neurological symptoms

called post-treatment Lyme Disease Syndrome. There is no cure for that, no drug, and no treatment. The only way to prevent this is to prevent Lyme, and a vaccine is a good answer for that,” says Pal.

As an expert in Borrelia and tick-borne disease, Pal is partnering with Matthias Schnell at Thomas Jefferson University, director of the Jefferson Vaccine Center known for the study and application of the rabies virus as a platform for vaccination. “We are using the rabies virus as a delivery platform to send in some vaccine candidates for Borrelia,” explains Pal. “For rabies, we can produce an inactivated virus that helps the body produce the antibodies needed to fight it. Since we can produce the rabies vaccine and antibody proteins safely, why not have this virus produce other types of proteins that can do something else, like fight Borrelia?”

This is an approach that Schnell and colleagues have studied and proven effective for other viral vaccinations, but it has not been previously explored for Borrelia and tick-borne diseases. Using proteins that Pal’s lab previously identified as vaccine candidates, Pal and his team hope to combine these proteins with the rabies virus to deliver long-lasting, safe, and effective immunity. This includes testing not only the four candidate proteins, but also three major types of rabies vaccine platforms that could be effective for Lyme disease.

“Viral vaccines are produced three different ways,” explains Pal. “The first is live attenuated virus, meaning that the virus is whole and viable, but you can make it incapable of producing full blown infection. The second type of vaccine, which is more popular for safety and efficacy and is the platform for the actual rabies vaccine, is an inactivated virus. It’s the whole virus, but it is inactivated and dead. And for the third type of vaccine, we take a protein from the virus or just a piece of the virus and produce a virus-like particle or VLP. In this case, you create a sort of shell of a virus that looks like the virus and has viral proteins on the outside but no actual virus on the inside, so the body is tricked into developing defenses against the virus itself.”

In their novel approach to developing a Lyme disease vaccine, Pal and Schnell will be examining all three of these possible platforms, using the rabies virus itself as the ultimate delivery method.

“Each vaccine has two parts,” says Pal. “One is actually the target protein or the antigen, and the other is how you deliver this to the human. This is important. If you take a protein and you inject it into the animal, there will be nothing, the protein will just disappear into the bloodstream. That is why vaccines use adjuvant chemicals, a compound that makes the antigen stable so the immune system can recognize it, see it, and mount an immune response. The best adjuvants aren’t safe for humans. But if we use the virus platform, we don’t need adjuvant because the virus acts like an adjuvant and often produces a strong immune response. So we are using the virus’ ability to produce a strong immune response to supply the Borrelia proteins and produce the appropriate antibodies.”

In addition to this unique approach, Pal is also looking at stopping Borrelia infection from two different sides, targeting both Borrelia proteins and the tick proteins that actually help keep the bacteria alive and ensure it can be transferred to humans. “It is like we are trying to dismantle the train [Borrelia] and the tracks [the delivery mechanism from ticks to humans] at the same time, which has never been done before,” says Pal. “Tick proteins are helping Borrelia, and with the vaccine, we would like to develop antibodies so that when the tick starts to feed, those antibodies will bind to tick targets as well as Borrelia and try to prevent the infection.” To do this, Pal will target proteins previously identified by his lab, including two Borrelia proteins published in The Journal of Infectious Diseases (BB0405 and BBI39) and two parts of a tick protein published in The Journal of Biological Chemistry.

Once the best combination of vaccine platform and protein antigens is identified, Pal and his team will test this option in mice to examine the underlying protection mechanisms of the vaccine and determine its overall effectiveness.

“This is an exciting project because we are able to repurpose the very effective rabies virus delivery platform to create something new,” says Pal. “Lyme disease is a very prevalent infection, but with a cure that doesn’t work for everyone. These chronic cases create long-term problems for diagnosis and treatment, and those patients are very difficult to manage. If we can produce something effective for Lyme disease, we can help with this problem and also understand how we can apply it to other tick-borne diseases.”

This work is funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), Project Number 1R01AI154542-01.

Share article on social media or email:

NucleusHealth’s cloud-based medical image management platform is acquired by Change Healthcare


News Image

NucleusHealth today announced the acquisition of Nucleus.io, a fully enabled cloud-native imaging and workflow technology platform, by Change Healthcare (Nasdaq: CHNG).

Nucleus.io’s advanced cloud native imaging technology, including a zero-footprint diagnostic viewer with patented streaming technology, workflow and image sharing solutions, completes Change Healthcare’s next generation medical imaging platform.

This will significantly accelerate Change Healthcare’s timeline to implement a complete cloud-based, end-to-end Enterprise Imaging solution with customers. Nucleus.io expands Change Healthcare’s addressable market by leveraging the over 7,500 organizations Nucleus.io currently serves.

Change Healthcare’s Enterprise Imaging Network (EIN) is the first of its kind, fully managed, cloud native platform. The foundations of the platform, including its Archive and Analytics applications, have been successfully delivered to the market as a cloud-native solution. The combination of both companies’ technologies and experienced teams will enable physicians to read, diagnose and collaborate from anywhere, reduce IT complexities and leverage data and Artificial Intelligence (AI) to improve outcomes.

“Now more than ever, customers are seeking ways to lower cost, reduce complexity, protect their patient data and deliver the best care possible. Our next generation Enterprise Imaging Network platform helps meet those needs in ways not previously possible and delivers exceptional value to our customers,” said Tracy Byers, senior vice president and general manager, Enterprise Imaging, Change Healthcare. “This transaction will accelerate the realization of our vision and the innovation our industry has been waiting for.”

“We began our technology journey eight years ago with the goal of improving patient care by using the power of the web to make medical imaging instantly accessible to patients, providers and hospitals.” Said Dr. Vishal Verma, Chief Executive Officer of NucleusHealth. “Change Healthcare was the clear choice when searching for an organization to deliver our technology to the world. We couldn’t be happier about the opportunity to have Change Healthcare bring our unified vision to light. Finding a partner that also puts customers and patients first was critical in our evaluation of the exciting opportunity to work with Change Healthcare. We are grateful to our partners and want to thank Triple Tree Capital Partners, Bon Secours Mercy Health and Children’s Hospital of Colorado. Our organization will continue to be a user of the Nucleus.io technology as we continue to service our 450 teleradiology facilities. We are very excited about the future of our StatRad teleradiology business and we look forward to continuing to serve our clients in that segment of NucleusHealth.”

To learn more about Change Healthcare Enterprise Imaging™, please visit the Enterprise Medical Imaging page.

About NucleusHealth

NucleusHealth is advancing patient care by facilitating medical image interpretation through the company’s award winning StatRad teleradiology service. Founded in 1996, by radiologists for radiologists, the company develops and implements forward-thinking solutions for radiology groups. For more information, call us at +1(858)251-3400, visit us at http://www.nucleushealth.io, or connect with us on Twitter or LinkedIn.

Share article on social media or email:



Boarding for Breast Cancer to Host 16th Annual Virtual Skate the Lake


Boarding for Breast Cancer Skate the Lake 2019 Photographer: Andrew Sergeant

“We are excited to be hosting the 16th Annual Skate the Lake VIRTUALLY for the first time this year. Now people worldwide can participate in this awesome event, and get educated on breast cancer prevention while being active in their communities.” Lisa Hudson, B4BC President and Co-Founder

Boarding for Breast Cancer (B4BC), a 501(c)3 nonprofit foundation providing breast cancer education, prevention and survivor support programs for young people, announced they will be hosting their 16th annual Skate the Lake event VIRTUALLY today. Historically this beloved community event is a 28-mile skate bike roll around beautiful Lake Tahoe and the majestic Truckee River. Due to COVID-19 this year’s event will be 100% VIRTUAL! Let your local trail, path, or neighborhood serve as the setting for the push to fundraise and raise awareness for breast cancer prevention. Skate Bike Roll on August 29 in the spirit of Skate the Lake whether that is 28 miles, 7 miles or even just a few laps around your block!

B4BC welcomes people to join in the efforts of reaching their fundraising goal of $30K for their education, prevention, and survivorship programs by registering or donating USING THIS LINK. Each participant is required to raise or donate a minimum of $25 to join in the fun, and registration prior to August 21st is encouraged to secure a special B4BC branded face covering and an entry to win a Yeti cooler.

“We are excited to be hosting the 16th Annual Skate the Lake VIRTUALLY for the first time this year,” said Lisa Hudson, B4BC President and Co-Founder. Now people worldwide can participate in this awesome event, and get educated on breast cancer prevention while being active in their communities.”

Virtual participation will be celebrated and highlighted on @B4BC’s Instagram story through shared tags #push4b4bc and #skatethelake. There will be incredible partner prizes awarded to the top 3 fundraisers and lots of opportunities to win additional prizes with raffle tickets, spirit and T shirt contests and more.

B4BC would like to thank all partners for making VIRTUAL Skate the Lake possible including: Yeti, Traeger Grills, Suja, Tahoe Longboards, The North Face, Pura Vida, Blendtec, Go Pro, Vans, Smith, Gnu, Arbor Collective, VonZipper, Nikita, Dakine, Sector 9, and lodging Granlibakken Resort, The Village at Squaw, River Ranch Lodge, North Lake Tahoe Resort Association, and many more!

Check out our 2019 Skate the Lake video HERE to see what the magic of this event is all about! Shareable social assets and event photos can be found HERE.

REGISTER / MORE INFO: B4BC.ORG

About B4BC:

Boarding for Breast Cancer (B4BC) is a 501(c)3 non-profit organization that advocates early detection and a healthy, active, and conscious lifestyle as the best means of breast cancer prevention. Founded in 1996, B4BC empowers young people to make positive choices that promote lifelong wellness through grassroots events, educational outreach, sustainability, and survivorship support programs.

Share article on social media or email:

Southern Veterinary Partners Celebrates Unstoppable Growth As It Welcomes 150th Location


SVP Logo

Southern Veterinary Partners

“By welcoming our 150th hospital, we’ve reached an important landmark in what has truly been an amazing journey of growth. It’s quite fitting that in spite of our regional presence, we’ve achieved this landmark back here in Birmingham where it all began.” – Dr. Jay Price, Founder and CEO of SVP

Southern Veterinary Partners (SVP) recently welcomed Britt Animal Hospital located in Birmingham, Alabama to its fast-growing family of veterinary-owned and managed animal hospitals, reaching an impressive milestone of 150 locations across 15 states.

Founded just shy of six years ago, SVP grew from its humble origins into a powerhouse in the animal health space with a simple mission: to be a community of veterinary teams providing personalized care with exceptional hospitality.

True to this mission, SVP provides centralized support to the veterinary practices within its fold, enabling them to leverage the organization’s infrastructure to support marketing, HR, finance, inventory, purchasing management, and access to enhanced employee benefits while being able to retain what makes each practice unique — their identities, culture, staff, and commitment to respective local communities.

Asked about the recent milestone, Dr. Jay Price, Founder and CEO of SVP who started the organization with his own animal hospital in Birmingham, Oak View Animal Hospital, enthusiastically reflected, “By welcoming our 150th hospital, we’ve reached an important landmark in what has truly been an amazing journey of growth. It’s quite fitting that in spite of our regional presence, we’ve achieved this landmark back here in Birmingham where it all began.”

As the COVID-19 pandemic continues to bring uncertainties to businesses everywhere, SVP is proving to be an indispensable ally for veterinary practices who are now having to navigate new challenges along with old compounded ones.

“SVP is one big working family which is why it is in our organizational DNA to help our partners and their practices succeed. It’s an honor for us to be able to help groups such as Britt Animal Hospital who continue to go above and beyond for their communities even during these uncertain times. We simply could not be more driven in our mission and more proud of the groups we do it for,” Dr. Price continued.

With its remarkable growth, Southern Veterinary Practices employs around 3,000 employees regionally to date. The organization’s success has not gone unnoticed, landing them well-deserved industry accolades early on, most notably Inc. 5000’s List of “Fastest Growing Companies in America” (2018 – 2020) and the Birmingham Business Journal’s “FastTrack 30” of the Fastest Growing Companies in Birmingham (2017 – 2018).

About Southern Veterinary Partners

Southern Veterinary Partners, LLC (SVP) is a veterinarian-owned and managed regional network of animal hospitals providing the highest quality veterinary care to companion animals. The company is based in Birmingham, Alabama and is known for its stellar record of providing exceptional client care. Visit http://www.svp.vet for more information.

Share article on social media or email:

Inc. Magazine Unveils Its Annual List ofAmerica’s Fastest-Growing Private Companies—the Inc. 5000


News Image

Our team has worked diligently on lowering the hospital readmission rates of our partners and creating a smoother transition of care to home.

Inc. magazine revealed that Georgetown Home Care is No. 3441 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

“We are so happy to once again be included in the list of the fastest growing companies in the US,” said John bradshaw, CEO of Georgetown Home Care. “It is a real testament to our team internally and all of their hard work, as well as the partnerships we have created with hospitals and skilled nursing facilities all over our region. Our team has worked diligently on lowering the hospital readmission rates of our partners and creating a smoother transition of care to home.”

Not only have the companies on the 2020 Inc. 5000 been very competitive within their markets, but the list as a whole shows staggering growth compared with prior lists as well. The 2020 Inc. 5000 achieved an incredible three-year average growth of over 500 percent, and a median rate of 165 percent. The Inc. 5000’s aggregate revenue was $209 billion in 2019, accounting for over 1 million jobs over the past three years.

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at http://www.inc.com/inc5000. The top 500 companies are also being featured in the September issue of Inc., available on newsstands August 18.

“The companies on this year’s Inc. 5000 come from nearly every realm of business,” says Inc. editor-in-chief Scott Omelianuk. “From health and software to media and hospitality, the 2020 list proves that no matter the sector, incredible growth is based on the foundations of tenacity and opportunism.”

The annual Inc. 5000 event honoring the companies on the list will be held virtually from October 23 to 27, 2020. As always, speakers will include some of the greatest innovators and business leaders of our generation.

Georgetown Home Care is the premier non-medical agency with offices in DC, Maryland and Virginia. Its mission is to ensure a better quality of life for elderly clients and their families by providing dependable and affordable care. Georgetown Home Care is a locally owned and operated company and is passionate about serving seniors and those in need with hourly and live-in care services.

CONTACT: For additional information about Georgetown Home Care, please contact Jessica Salgado, 202.333.3400, jessicasalgado@georgetownhomecare.com.

More about Inc. and the Inc. 5000

Methodology

The 2020 Inc. 5000 is ranked according to percentage revenue growth when comparing 2016 and 2019. To qualify, companies must have been founded and generating revenue by March 31, 2016. They had to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2019. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2016 is $100,000; the minimum for 2019 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Companies on the Inc. 500 are featured in Inc.’s September issue. They represent the top tier of the Inc. 5000, which can be found at http://www.inc.com/inc5000.

About Inc. Media

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit http://www.inc.com.

For more information on the Inc. 5000 Conference, visit http://conference.inc.com/.

Share article on social media or email: